Cullen Frost Bankers »

Akero Therapeutics shares owned by Cullen Frost Bankers

Quarter-by-quarter ownership of Akero Therapeutics (AKRO) shares owned by Cullen Frost Bankers from 13F filings

Historical chart of Cullen Frost Bankers investment in Akero Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Akero Therapeutics held by Cullen Frost Bankers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Akero Therapeutics by Cullen Frost Bankers

Quarter filed Position value Share count Share price at filing
2023-12-31 $3.5k 150 23.35
2023-09-30 $7.6k 150 50.58

More positions owned by Cullen Frost Bankers

Apple Domestic Common Stock (AAPL)
Microsoft Corp Domestic Common Stock (MSFT)
Vanguard Index Fds Growth Etf Domestic Large Cap Fund-etf (VUG)
Amazon Domestic Common Stock (AMZN)
Ishares Tr Msci Eafe Etf Intl Developed Mkts Fund-etf (EFA)
Ishares Tr Rus 1000 Grw Etf Domestic Large Cap Fund-etf (IWF)
Vanguard Index Fds Mid Cap Etf Domestic Mid Cap Fund-etf (VO)
Spdr S&p 500 Etf Tr Tr Unit Domestic Large Cap Fund-etf (SPY)
Visa Inc Com Cl A Domestic Common Stock (V)
Alphabet Inc Cap Stk Cl A Domestic Common Stock (GOOGL)
Alphabet Inc Cap Stk Cl C Domestic Common Stock (GOOG)
Schwab Strategic Tr Us Dividend Eq Domestic Large Cap Fund-etf (SCHD)
Flexshares Tr Mornstar Upstr Domestic Sector Fund-etf (GUNR)
Nvidia Corporation Domestic Common Stock (NVDA)
Ishares Tr 20 Yr Tr Bd Etf Domestic Taxable Invt Grade-etf (TLT)

View all positions for Cullen Frost Bankers

Top funds holding Akero Therapeutics

Henderson Group
T. Rowe Price Associates
Vanguard Group
Wellington Management Company
Baker Bros. Advisors
Yiheng Capital
Boxer Capital
Alliancebernstein
Redmile Group
Perceptive Advisors
Logos Global Management
Point72 Asset Management
Citadel Advisors
Goldman Sachs Group
Holocene Advisors

View all funds holding Akero Therapeutics